Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

EPA:ALTUV - Euronext Paris - Matif - FR0013345493 - Common Stock - Currency: EUR

1.89  -0.02 (-0.84%)

Fundamental Rating

4

Taking everything into account, ALTUV scores 4 out of 10 in our fundamental rating. ALTUV was compared to 103 industry peers in the Machinery industry. ALTUV has a bad profitability rating. Also its financial health evaluation is rather negative. ALTUV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALTUV had negative earnings in the past year.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in each of the past 5 years.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

With a Return On Assets value of 0.05%, ALTUV is not doing good in the industry: 73.79% of the companies in the same industry are doing better.
With a Return On Equity value of 0.10%, ALTUV is not doing good in the industry: 73.79% of the companies in the same industry are doing better.
The Return On Invested Capital of ALTUV (3.03%) is worse than 68.93% of its industry peers.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.91%. This is below the industry average of 8.83%.
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROIC 3.03%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Profit Margin of ALTUV (0.08%) is worse than 72.82% of its industry peers.
ALTUV's Profit Margin has declined in the last couple of years.
ALTUV has a Operating Margin (5.39%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
ALTUV has a Gross Margin (37.34%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
Industry RankSector Rank
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALTUV has less shares outstanding
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALTUV (1.49) is worse than 66.02% of its industry peers.
ALTUV has a debt to FCF ratio of 4.83. This is a neutral value as ALTUV would need 4.83 years to pay back of all of its debts.
ALTUV's Debt to FCF ratio of 4.83 is in line compared to the rest of the industry. ALTUV outperforms 59.22% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that ALTUV is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, ALTUV is not doing good in the industry: 62.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Altman-Z 1.49
ROIC/WACC0.46
WACC6.65%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.64 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a Current ratio of 1.64. This is comparable to the rest of the industry: ALTUV outperforms 51.46% of its industry peers.
ALTUV has a Quick Ratio of 1.64. This is a bad value and indicates that ALTUV is not financially healthy enough and could expect problems in meeting its short term obligations.
ALTUV's Quick ratio of 0.84 is on the low side compared to the rest of the industry. ALTUV is outperformed by 66.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.84
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The earnings per share for ALTUV have decreased strongly by -66.19% in the last year.
The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -8.23% in the last year.
ALTUV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.65% yearly.
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%

3.2 Future

The Earnings Per Share is expected to grow by 48.32% on average over the next years. This is a very strong growth
ALTUV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.18% yearly.
EPS Next Y99.99%
EPS Next 2Y48.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.89%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

6

4. Valuation

4.1 Price/Earnings Ratio

ALTUV is valuated reasonably with a Price/Forward Earnings ratio of 9.19.
76.70% of the companies in the same industry are more expensive than ALTUV, based on the Price/Forward Earnings ratio.
ALTUV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.60.
Industry RankSector Rank
PE N/A
Fwd PE 9.19
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALTUV.
93.20% of the companies in the same industry are more expensive than ALTUV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.39
EV/EBITDA 8.61
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 48.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.32%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 2.93, ALTUV pays a bit more dividend than its industry peers.
ALTUV's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y48.32%
EPS Next 3YN/A
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (6/30/2025, 7:00:00 PM)

1.89

-0.02 (-0.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-03 2025-04-03/amc
Earnings (Next)09-17 2025-09-17
Inst Owners6.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.74M
Analysts86.67
Price Target3.06 (61.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.19
P/S 0.68
P/FCF 5.39
P/OCF 3.88
P/B 0.82
P/tB N/A
EV/EBITDA 8.61
EPS(TTM)0
EYN/A
EPS(NY)0.21
Fwd EY10.89%
FCF(TTM)0.35
FCFY18.56%
OCF(TTM)0.49
OCFY25.8%
SpS2.8
BVpS2.31
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.05%
ROE 0.1%
ROCE 4.13%
ROIC 3.03%
ROICexc 3.28%
ROICexgc 14.19%
OM 5.39%
PM (TTM) 0.08%
GM 37.34%
FCFM 12.54%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexcg growth 3Y38.43%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 4.83
Debt/EBITDA 3.4
Cap/Depr 58.57%
Cap/Sales 4.9%
Interest Coverage 250
Cash Conversion 126.83%
Profit Quality 15804.5%
Current Ratio 1.64
Quick Ratio 0.84
Altman-Z 1.49
F-Score5
WACC6.65%
ROIC/WACC0.46
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.19%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%69.84%
EPS Next Y99.99%
EPS Next 2Y48.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.23%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-8.01%
Revenue Next Year13.89%
Revenue Next 2Y9.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.12%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year209.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.04%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y10.6%
OCF growth 3Y27.9%
OCF growth 5YN/A